dc.contributor.author | Hernandez, D | en_US |
dc.contributor.author | Janmohamed, A | en_US |
dc.contributor.author | Chandan, P | en_US |
dc.contributor.author | Omar, BA | en_US |
dc.contributor.author | Phillips, IR | en_US |
dc.contributor.author | Shephard, EA | en_US |
dc.date.accessioned | 2011-04-28T15:16:50Z | |
dc.date.issued | 2009-04 | en_US |
dc.identifier.issn | 1744-6872 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/955 | |
dc.format.extent | 289 - 299 | en_US |
dc.relation.ispartof | PHARMACOGENET GENOM | en_US |
dc.subject | behavioural response | en_US |
dc.subject | chromosomal engineering | en_US |
dc.subject | drug metabolism | en_US |
dc.subject | flavin-containing monooxygenase | en_US |
dc.subject | imipramine | en_US |
dc.subject | knockout mice | en_US |
dc.subject | pharmacogenetics | en_US |
dc.subject | FLAVIN-CONTAINING MONOOXYGENASES | en_US |
dc.subject | PERFORMANCE LIQUID-CHROMATOGRAPHY | en_US |
dc.subject | N-OXIDE | en_US |
dc.subject | HUMAN LIVER | en_US |
dc.subject | METABOLISM | en_US |
dc.subject | EXPRESSION | en_US |
dc.subject | PLASMA | en_US |
dc.subject | DESIPRAMINE | en_US |
dc.subject | MICE | en_US |
dc.subject | POLYMORPHISM | en_US |
dc.title | Deletion of the mouse Fmo1 gene results in enhanced pharmacological behavioural responses to imipramine | en_US |
dc.type | Article | |
dc.rights.holder | © 2009 Lippincott Williams & Wilkins, Inc. | |
dc.identifier.doi | 10.1097/FPC.0b013e328328d507 | en_US |
pubs.issue | 4 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 19 | en_US |